Dr. Sasine On Car T-Cell Therapy In Ovarian Cancer

Dr. Sasine on CAR T-Cell Therapy in Ovarian Cancer

Dr. Sasine on Predicting Individual Benefit with CAR T Cells

Dr. Sasine on Determining Outlook With CAR T-Cell Therapy in Hematologic Cancers

Dr. Sasine on New Developments With CAR T-Cell Therapy

CAR T-Cell Therapy - Joshua Sasine, MD, PDH | Closer to a Cure Series

Dr. John Mullinax at SITC 2022: CAR T therapy with ovarian cancer.

Moffitt Cancer Center

Dr. Robert Wenham at SITC 2022: CAR T therapy with ovarian cancer.

Moffitt Cancer Center

(Overview) CAR-T Cell Therapy of Ovarian Cancer

The Society for Translational Oncology

Study finds hope for ovarian cancer patients in new immunotherapy

Medical Dialogues

Dr. Konstantinopoulos on Immunotherapy in Ovarian Cancer

NY-ESO-1 immunotherapy for ovarian cancer

WEBINAR: CAR T Cell Therapy

Canadian Cancer Survivor Network

Rationale for Immunotherapy in Ovarian Cancer

Dr. Sadelain on CAR T-Cell Therapies

Dr. O’Malley on Research With Immunotherapy in Ovarian Cancer

What is CAR T-Cell Therapy?

Michigan Medicine

Dr. Hays on Immunotherapy in Ovarian Cancer Treatment

Challenges of CAR T-cells in solid tumors

VJHemOnc – Video Journal of Hematology & HemOnc

SciTalk: Engineering adoptive T cell therapy for efficacy in ovarian cancer

KeystoneSymposia

CAR-T cells versus SPEAR T-cells to treat solid tumors